Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

June 23, 2026 8:30 AM

Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W. Meyer, outlining the Company's strategic progress in 2025 and the initiatives positioning the Company for growth in 2026 and beyond. To Our Shareholders: 2025 was a year...

Read more
Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer
Healthcare & PharmaceuticalManagement Changes

Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer

June 23, 2026 8:00 AM

KIFFIK Biomedical today announced that Luigi (Gino) Martini, Ph.D., FRPharmS, MBA, has been appointed Chief Scientific Officer (CSO). Dr. Martini's career spans senior leadership roles across global pharmaceutical companies including GSK, Roche, Shire, and Catalent, as well as academic appointments at King's College London and policy leadership at the Royal Pharmaceutical Society. His work has focused on oncology, rare diseases, precision...

Read more
LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System
Healthcare & PharmaceuticalCompany Update

LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System

June 23, 2026 7:00 AM

LEM Surgical Inc., a pioneer in advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted an additional 510(k) clearance for its Dynamis Robotic Surgical System. This landmark milestone introduces further capabilities to the groundbreaking, surgical humanoid architecture that is focused on the global orthopedic and spine surgery market. The Dynamis Robotic Surgical System...

Read more
Who Does the Best Mini Lift in Florida?
Healthcare & PharmaceuticalAdvertorial

Who Does the Best Mini Lift in Florida?

June 23, 2026 6:00 AM

As demand grows for facial rejuvenation procedures with shorter recovery times and natural-looking outcomes, many patients are searching for surgeons who specialize in mini facelift techniques rather than traditional full facelift surgery. In Florida, where cosmetic facial procedures remain among the most requested aesthetic surgeries, patients increasingly compare surgeons based on training, procedural innovation, surgical volume, and long-term...

Read more
Who Is Really Influencing Trump Marijuana Rescheduling?
Healthcare & PharmaceuticalCompany Update

Who Is Really Influencing Trump Marijuana Rescheduling?

June 23, 2026 1:25 AM

On June 29, the Drug Enforcement Administration (DEA) will convene what may become the most consequential marijuana hearing in modern American history. The hearing is intended to help build the administrative record supporting-or opposing-the proposed transfer of marijuana from Schedule I to Schedule III under the Controlled Substances Act. That record is supposed to be built on evidence. Chemistry. Manufacturing controls. Pharmacology....

Read more
Manjuba Drops Review 2026: Ingredients, Safety & Buyer Guide
Healthcare & PharmaceuticalAdvertorial

Manjuba Drops Review 2026: Ingredients, Safety & Buyer Guide

June 22, 2026 9:40 PM

Quick disclosure before we get into it: Manjuba Drops is a dietary supplement, not a drug or FDA-approved treatment. These statements haven't been evaluated by the Food and Drug Administration. This product isn't intended to diagnose, treat, cure, or prevent any disease. Individual results vary. If you're on prescription medications or managing a health condition, check with your doctor before adding any supplement. That's not boilerplate - it's...

Read more
Omzo GLP-1 Review 2026: Is This Compounded Semaglutide Telehealth Program Legit - Pricing, FDA Enforcement Context, and What to Verify Before Your First Dose
Healthcare & PharmaceuticalAdvertorial

Omzo GLP-1 Review 2026: Is This Compounded Semaglutide Telehealth Program Legit - Pricing, FDA Enforcement Context, and What to Verify Before Your First Dose

June 22, 2026 8:35 PM

Title Reference Notice: Promotional language used in the title above - including "GLP-1 Review 2026" and "What Buyers Need to Know Before Starting" - reflects consumer education framing consistent with how the Omzo brand positions its telehealth weight-loss program at omzo.com. "Personalized care" and "GLP-1 medication" are terms used in Omzo's published marketing materials to describe its clinician-guided telehealth service. This publication...

Read more
Trimi GLP-1 Review 2026: What the $99 Compounded Semaglutide Platform Discloses - And What to Confirm Before You Enroll
Healthcare & PharmaceuticalAdvertorial

Trimi GLP-1 Review 2026: What the $99 Compounded Semaglutide Platform Discloses - And What to Confirm Before You Enroll

June 22, 2026 8:25 PM

If you searched "Trimi GLP-1 review" before pulling out your credit card, you made the right call. This article verifies what's publicly documented about the platform - the pharmacy license numbers, the clinical network structure, the refund policy terms, and the FDA regulatory context that's changed significantly since 2024 - so you can make an informed decision rather than a hopeful one. Advertorial Disclosure: This article is promotional in...

Read more
SoCalBio Unveils New Brand Reflecting Greater LA's Growth as a Global Bioscience Hub
Healthcare & PharmaceuticalCompany Update

SoCalBio Unveils New Brand Reflecting Greater LA's Growth as a Global Bioscience Hub

June 22, 2026 6:30 PM

SoCalBio, the leading trade association representing the life sciences, medical technology and biopharmaceutical community in Greater Los Angeles, today unveiled a new brand identity at the BIO International Convention. Created by SoCalBio member RKS Design, the rebrand reflects both the transformation of the region's bioscience ecosystem and SoCalBio's growing role in uniting innovators, entrepreneurs, and researchers with industry leaders and...

Read more
ZetrOZ Systems Introduces sam 3.0 Multi-hour Continuous Ultrasound Wearable Technology, The Next Evolution in Recovery
Healthcare & PharmaceuticalProduct Announcements

ZetrOZ Systems Introduces sam 3.0 Multi-hour Continuous Ultrasound Wearable Technology, The Next Evolution in Recovery

June 22, 2026 1:20 PM

ZetrOZ Systems, the inventor of sustained acoustic medicine, today announces the launch of sam® 3.0, the latest evolution of its revolutionary wearable ultrasound device that has been clinically validated in more than 30 studies as accelerating healing and recovery from soft-tissue injuries. Built on the technological foundation of the sam® 2.0 device, the new device provides significant enhancements in battery performance, charging speed, user...

Read more
Marijuana Rescheduling DEA Judge Violates the Constitution? DEA Is Holding a ALJ Hearing Next Week
Healthcare & PharmaceuticalCompany Update

Marijuana Rescheduling DEA Judge Violates the Constitution? DEA Is Holding a ALJ Hearing Next Week

June 22, 2026 11:50 AM

MMJ International Holdings, together with its subsidiaries MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), is asking a simple question ahead of the Drug Enforcement Administration's June 29 marijuana rescheduling hearing: If the Department of Justice has already acknowledged a constitutional defect in the Administrative Law Judge system, why is DEA proceeding as though the problem does not exist? The question...

Read more
Vanna Health Raises $17 Million to Expand Evidence-Based Care for People Living with Serious Mental Illness
Healthcare & PharmaceuticalFinancing

Vanna Health Raises $17 Million to Expand Evidence-Based Care for People Living with Serious Mental Illness

June 22, 2026 10:00 AM

Vanna Health, a value-based health technology company that provides integrated mental and chronic health support through community-based coaching, today announced the close of a $17 million funding round. The round was co-led by a national insurer and AlleyCorp, with participation from Health Velocity Capital. The funding will support the expansion of Vanna Health's clinical reach, deepen its technology infrastructure, and bring its...

Read more
Pharmacist and IT Researcher Ramchandra Pudasaini Explores AI-Driven Medication Management and Healthcare Data Integration
Healthcare & PharmaceuticalAdvertorial

Pharmacist and IT Researcher Ramchandra Pudasaini Explores AI-Driven Medication Management and Healthcare Data Integration

June 22, 2026 10:00 AM

From Pharmacy to Artificial Intelligence: How Ramchandra Pudasaini Is Exploring Technology-Driven Solutions for Medication Management and Healthcare Innovation Healthcare systems worldwide continue to face challenges related to medication errors, fragmented healthcare data, disconnected clinical workflows, and increasing demands for data-driven decision-making. While digital transformation continues to reshape healthcare delivery, the challenge...

Read more
NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Healthcare & PharmaceuticalCompany Update

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo

June 22, 2026 9:30 AM

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today announced that it has shipped the NV-387 Oral Gummies Drug Product for a Phase II Clinical Trial of Monkeypox Treatment to the Democratic Republic of Congo (DRC), in preparation for enrollment of patients. Clinical Trial Site preparations are being performed by our CRO in India, Om Sai Clinical Research Pvt. Ltd., and associates in DRC. The CRO personnel have visited the site several...

Read more
MDCE's RealGameUsed.com Launches Revolutionary Online Memorabilia Authentication Platform, First in Industry for Fully Digital Photo Match Submissions
Healthcare & PharmaceuticalProduct Announcements

MDCE's RealGameUsed.com Launches Revolutionary Online Memorabilia Authentication Platform, First in Industry for Fully Digital Photo Match Submissions

June 22, 2026 9:11 AM

Real Game Used (RGU), a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), today announced the launch of its brand new website featuring a brand new online authentication portal for memorabilia collectors. Collectors can now submit items for photo match authentication directly through the portal by uploading titles, details, documentation scans, and item images, receive instant pricing, and track their order status in real time...

Read more
CVS Continues To Celebrate Soccer With Community Events
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Continues To Celebrate Soccer With Community Events

June 22, 2026 9:00 AM

CVS Pharmacy® continues to celebrate soccer and its powerful impact on community by bringing activations directly to fans. This summer, CVS will help make the thrill of the game accessible in communities nationwide by hosting in-store events, offering officially licensed FIFA merchandise, and ultimately serving as a one-stop shop for match-day essentials. Through mid-July, CVS is hosting family-friendly soccer block parties at select locations...

Read more
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Healthcare & PharmaceuticalCompany Update

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program

June 22, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value and aligned with our anticipated completion of the clinical work supporting our filing of a New Drug Application (NDA) by the Company for our crofelemer-based prescription drug candidate for rare intestinal failure...

Read more
Black Book Research Spotlights 2026 Front-End Access and Patient Financial Experience Leaders in Hospital RCM
Healthcare & PharmaceuticalAwards

Black Book Research Spotlights 2026 Front-End Access and Patient Financial Experience Leaders in Hospital RCM

June 22, 2026 8:31 AM

Black Book Research's 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report identifies a focused group of top client-rated vendors supporting the front end of hospital revenue cycle management, where patient access, financial clearance, affordability, identity accuracy and payment experience increasingly determine downstream cash performance. The full 2026 RCM report names #1 vendors across 49 hospital RCM...

Read more
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
Healthcare & PharmaceuticalCompany Update

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

June 22, 2026 8:30 AM

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026. Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions: +60% revenue growth to $8 million in 2025 +70% revenue growth to $2.5 million in Q1...

Read more
Dr. Ammar Mahmoud Explains How Minimally Invasive Labiaplasty Is Changing Cosmetic Gynecology
Healthcare & PharmaceuticalCompany Update

Dr. Ammar Mahmoud Explains How Minimally Invasive Labiaplasty Is Changing Cosmetic Gynecology

June 22, 2026 7:25 AM

Cosmetic gynecology is changing rapidly as more patients seek minimally invasive procedures with shorter recovery times and more natural-looking results. According to cosmetic gynecological surgeon Dr. Ammar Mahmoud, the growing interest in minimally invasive labiaplasty reflects a broader shift in aesthetic medicine toward precision, preservation, and patient-centered care. Patients today are asking different questions than they did a decade...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?